Document:

Exhibit 10.3

 

Execution Copy

 

TECHNOLOGY
LICENSE AGREEMENT

 

THIS
TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is entered into as of March 23, 2012 by and between I-Pulse
Inc., a company organized under the laws of the state of Delaware (formerly known as Bfield USA Inc.) (“I-Pulse”),
and High Power Exploration Inc., a company organized under the laws of the state of Delaware (formerly known as GoviEx IP Holdings
Inc. and the assignee of a patent license from Govi High Power Exploration Inc.) (“HPX Delaware”) (each, a “Party,”
and collectively, the “Parties”).

 

WHEREAS,
I-Pulse owns or is the licensee of the Licensed Technology (as defined below);

 

WHEREAS,
I-Pulse intends to license the Licensed Technology to other Affiliates in other than the Licensed Field and expects that such Affiliated
companies will also be making Improvements to the subject matter of the Licensed Technology, which may benefit other licensees of the
Licensed Technology in other than its (the licensee making such Improvements) field of use (all capitalized terms as defined below);

 

WHEREAS,
HPX Delaware desires to obtain from I-Pulse, and I-Pulse is willing to grant to HPX Delaware, an exclusive, and for the lifetime of the
Licensed Patents and perpetual in the case of the Licensed Technology other than the Licensed Patents (subject to the termination provisions
hereinafter set forth), worldwide license for the use of the Licensed Technology within the Licensed Field and the worldwide right to
develop and commercialize the Licensed Products, subject to, and in accordance with, the terms and conditions set forth herein;

 

WHEREAS,
the Parties wish to amend, restate and rename the Amended and Restated Patent License Agreement entered into as of July 18, 2008 (the
 “Amended and Restated Patent License Agreement”) (which had amended and restated the Patent License Agreement dated
the 1st day of August, 2007), to, among other things, change the name of the agreement to “Technology License Agreement,”
make the Territory (as defined below) worldwide, modify the Field of Use (as defined below), expand the scope of the license, and modify
the license fee, ownership of HPX Delaware Improvements (as defined below) and termination rights;

 

WHEREAS,
HPX Delaware has made minimal, if any, HPX Delaware Improvements;

 

WHEREAS,
the Parties acknowledge that the expansion of the scope of the license will add substantial value to the license (after accounting for
the minimal, if any, value of the HPX Delaware Improvements assigned to I-Pulse hereunder and the changes in the scope of the license)
and that such increased value should be considered a contribution by I-Pulse to the capital of HPX Delaware; and

 

WHEREAS,
for the avoidance of doubt, the Amended and Restated Patent License Agreement is amended, restated and renamed for convenience only and
does not effect a termination of the Amended and Restated Patent License Agreement, but supersedes such agreement as of the date hereof.

 

     

     

    

 

NOW,
THEREFORE, in consideration of the mutual promises, representations and warranties contained herein, the Parties, intending
to be legally bound, hereby agree as follows:

 

	1.	Definitions.

 

1.1           “Affiliate” and “Affiliated” means (a) any other Person that, directly or indirectly,
through one or more intermediaries, controls, is controlled by, or is under common control with, such Person, or (b) any other Person,
including but not limited to subsidiaries, of which such Person owns, directly or indirectly, a twenty-five percent (25%) or greater equity
or voting interest. In addition, with respect to a Person that is an individual, “Affiliate” shall also include (x) the immediate
family of such individual, including, without limitation, his or her spouse, children and their spouses, grandchildren and any other descendants
by blood or adoption, and (y) any trust, limited liability company, partnership or other entity the equity owners or beneficiaries (as
applicable) of which are any of the individuals described in the foregoing clause (x). For purposes of clarification, “Affiliate”
of any Person shall also include any other Person that becomes an Affiliate of such Person after the date hereof.

 

1.2          
“Claim” means any demand, investigation, action, suit, proceeding, claim, assessment, judgment, settlement
or compromise relating, directly or indirectly, to: (a) the Licensed Technology, including without limitation the Licensed Patents, any
Patent Rights, Licensed Patent Rights or Licensed Product; and/or (b) this Agreement (including without limitation, the License contained
herein, the obligations of the Parties pursuant hereto and the representations and warranties made by the Parties herein).

 

 1.3           “Confidential Information” has the meaning ascribed thereto in Section 5.1.

 

1.4          
“Control” (including the terms “controlled by” and “under common control with”)
means, with respect to the relationship between or among two or more Persons, the possession, directly or indirectly, of the power to
direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting securities, as trustee
or executor, by contract or otherwise, including, without limitation, the ownership, directly or indirectly, of securities having the
power to elect a majority of directors or similar body governing the affairs of such Person.

 

 1.5           “Disclosing Party” has the meaning ascribed thereto in Section 5.1.

 

 1.6           “Force Majeure Event” has the meaning ascribed thereto in Section 11.10.

 

1.7          
“Governmental Authority” means any domestic or foreign, federal, national, state, multi- state, international,
multinational or municipal or other local government, any subdivision, agency, commission or authority thereof, or any quasi-governmental
or private body exercising any regulatory or taxing authority thereunder or any court or other tribunal or judicial authority.

 

 1.8           “HPX Delaware Improvements” has the meaning ascribed thereto in Section 4.1(c).

 

1.9          
“Improvements” means any enhancement, invention, variation, update, modification or discovery created,
identified or discovered by or on behalf of either Party with respect, directly or indirectly, to the subject matter of the Licensed Technology.

 

1.10         “Intellectual
Property Rights” means (a) all rights under all copyright laws of the United States and all other countries for the
full terms thereof (of all rights accruing by virtue of copyright treaties and conventions), including but not limited to all
renewals, extensions, reversions or restorations of copyrights now or hereafter provided by law and all rights to make applications
for and obtain copyright registrations therefor and recordations thereof, and including without limitation all copyright rights in
all software, documentation, user and application interfaces including without limitation the look and feel and the structure,
sequence and organization thereof; (b) all rights to and under new and useful inventions, discoveries, designs, technology and art
and all other patentable subject matter, including, but not limited to, all improvements thereof and all know-how related thereto,
and all applications for and the right to make applications for Letters Patent in the United States and all other countries, all
Letters Patents that issue therefrom and all reissues, extensions, renewals, divisions and continuations (including
continuations-in-part) thereof, for the full term thereof; (c) all trademarks, service marks and Internet domain names and the like
and the goodwill associated therewith throughout the world; (d) all trade secrets, confidential business information, evaluations
and reports; (e) all know-how under the laws of any jurisdiction and all know-how not otherwise included in the foregoing; and (f)
all other intellectual and industrial property and proprietary rights throughout the world not otherwise included in the foregoing,
including without limitation all techniques, methodologies and concepts and trade dress.

 

    2

     

    

 

1.11         “I-Pulse
Improvements” means any enhancement, invention, variation, update, modification or discovery created, identified or discovered
by or on behalf of I-Pulse or otherwise acquired by I-Pulse with respect, directly or indirectly, to the subject matter of the Licensed
Technology in the Licensed Field.

 

 1.12         “License” has the meaning ascribed thereto in Section 2.1.

 

1.13         “Licensed
Field” and “Field of Use” mean the use of the Licensed Technology for any purpose in the fields
listed in Schedule I.

 

1.14        
“Licensed Patents” means those patents and patent applications identified in Schedule I hereto
and any New Patents, and any Patent Rights, if any, of I-Pulse throughout the Territory with respect to the Licensed Field.

 

 1.15         “Licensed Patent Rights” means all Patent Rights with respect to the Licensed Patents.

 

1.16         “Licensed Product” means any present or future product or service within the Field of Use, the manufacture,
use, offer for sale, sale or performance of which: (a) incorporates, embodies or otherwise includes any of the Licensed Patents, I-Pulse
Improvements or related Intellectual Property Rights; or (b) would, absent the license granted to HPX Delaware hereunder, infringe or
misappropriate any of the Licensed Patent Rights, I-Pulse Improvements or related Intellectual Property Rights.

 

1.17         “Licensed
Technology” means the Licensed Patents, and all technology or Improvements (including, but not limited to, any Patent Rights
applicable to any such technology or Improvements thereof in whole or in part) developed by I-Pulse in the Licensed Field or in connection
with, related to, arising from, used in the making of and/or embodied in the Licensed Products (including, but not limited to, all modifications,
additions, enhancements and Improvements of any kind to the Licensed Patents and such technology) and all other Intellectual Property
Rights owned by or licensed to I-Pulse and associated with the Licensed Patents or such technology or Improvements during the term of
this Agreement. Without limitation of the foregoing, and for the avoidance of doubt, the foregoing shall include all know- how with respect
to the Zeus Transmitter.

 

1.18         “Losses” means and includes, but shall not be limited to, losses, liabilities, claims, damages, costs
(including, without limitation, the reasonable costs incurred in the enforcement of any indemnification obligations, or taxes), reasonable
legal fees (including reasonable attorneys’ fees and disbursements and costs of investigation, litigation and settlement), liabilities,
penalties and expenses incurred by the applicable Person.

 

1.19        
“New Patents” mean any patent and patent applications with respect to the I-Pulse Improvements.

 

    3

     

    

 

1.20        
“Patent Rights” means the rights and interests in and to issued patents and patent applications (including
inventors’ certificates and utility models) in any country or jurisdiction within the Territory, including all substitutions, continuations,
continuations-in-part, divisional applications, supplementary protection certificates, renewals, all Letters Patent granted thereon, and
all reissues, reexaminations, extensions, confirmations, revalidations, registrations, patents of addition and foreign counterparts.

 

1.21         “Person” means any individual, sole proprietorship, partnership, incorporated organization, association,
corporation, limited liability company, institution, public benefit corporation, any other entity, estate, trust, firm, company, government,
Governmental Authority or any joint venture (whether or not having a separate legal personality).

 

 1.22         “Receiving Party” has the meaning ascribed thereto in Section 5.1.

 

1.23         “Regulatory Approval” means all technical and other licenses, registrations, authorizations, permits
or approvals (including, without limitation, supplements, amendments, post- approvals, pricing and Third Party reimbursement approvals,
marketing authorizations based on such approvals, including any prerequisite manufacturing approvals or authorizations related thereto
and labeling approvals) of any national, federal, regional, provincial, state or local regulatory agency, department, bureau, commission,
council or other Governmental Authority, necessary for the development, manufacture, distribution, marketing, promotion, commercialization,
offer for sale, use, import, export or sale of the Licensed Products.

 

1.24        
“Sublicensee” means any Third Party to whom HPX Delaware grants a sublicense of some or all of the rights
granted to HPX Delaware under this Agreement.

 

 1.25         “Territory” means those countries and/or jurisdictions listed in Schedule I hereto.

 

1.26         “Third Party” and “Third Parties” mean one or more Persons other than HPX Delaware,
I-Pulse and their respective Affiliates.

 

	2.	Grant of Rights.

 

2.1           License.
Subject to the terms and conditions of this Agreement, I-Pulse hereby grants to HPX Delaware a royalty-free (subject to Section
2.2), fully paid-up, exclusive, perpetual (subject to the provisions of Section 8 hereof
and as further set forth below), license under all of I-Pulse’s Intellectual Property Rights within the Licensed Field,
throughout the Territory with respect to the Licensed Technology relating to any Licensed Product, to: (a) make, use, modify,
enhance and develop the Licensed Technology relating to any Licensed Product; and (b) develop, manufacture, promote, market,
distribute, sell, offer for sale and commercialize any and all Licensed Products; notwithstanding the foregoing, the term of the
license to the Licensed Patents incorporated in the Licensed Technology shall be for the terms of the respective Licensed Patents in
countries in the Territory where there are Patent Rights (subject to the provisions of Section 8 hereof),
(the “License”). For the avoidance of doubt, the sole and exclusive nature of the License herein granted
being acknowledged, I-Pulse, including, without limitation, any transferee, assignee or successor thereof, shall have no right to
deal in any way with (or exercise any right herein granted to HPX Delaware with respect to) the Licensed Patents or any Licensed
Product (including, without limitation, to manufacture, promote, market, distribute, sell, offer for sale and/or commercialize
Licensed Products) within the Licensed Field throughout the Territory, and any such purported right shall be null and void. The
Parties hereby further agree and confirm that the terms and conditions of the License granted herein, including without limitation
the aforesaid exclusivity, shall survive any change in Control of I-Pulse or the assignment, transfer or sale of all or
substantially all of the assets of I-Pulse, including, without limitation, any assignment, transfer or sale of all or substantially
all of the assets of I-Pulse by operation of law or otherwise.

 

    4

     

    

 

2.2           Royalty.
Commencing upon the date if and when I-Pulse owns directly or indirectly less than fifty-one percent (51%) of the equity or voting interest
in HPX Delaware, HPX Delaware shall pay I- Pulse a royalty fee to be negotiated upon commercially reasonable terms.

 

2.3           Publication
Rights. The License granted in Section 2.1 includes the right to disclose or make public any and all information, including
results, based on the work or activities carried out by HPX Delaware in connection with the development of Licensed Products or their
use within the Licensed Field other than trade secrets, know-how or other confidential or proprietary information with respect to the
Licensed Technology, the Licensed Products, and I-Pulse’s other business activities outside of the Licensed Field, which HPX Delaware
shall at all times keep confidential. HPX Delaware agrees not to disclose any information or make any public statements relating to the
use or application of the Licensed Technology, Licensed Products or the subject technology of the Licensed Technology as related to any
use other than the Licensed Field.

 

2.4           Recordation.
HPX Delaware and I-Pulse shall cooperate, at I-Pulse’s expense, to record this Agreement to the extent, if any, required by Governmental
Authorities in order to establish, perfect or enforce the Parties’ rights hereunder, provided that the terms of this Agreement
shall not be provided or otherwise disclosed except to the extent necessary to effect such recordation.

 

2.5           Right
to Sublicense. HPX Delaware shall have the unrestricted and unlimited right to grant sublicenses (subject, for the avoidance of doubt,
to the confidentiality provisions hereof) as to all or any portion of its rights under the License granted pursuant to Section 2.1
hereof to any Person as it in its sole discretion desires, provided that HPX Delaware shall indemnify I-Pulse for any and all Claims
made against or Losses incurred by I-Pulse as a direct result of any such sublicense.

 

2.6           Consideration.
Subject to Section 2.2, it is hereby acknowledged that the License granted herein is royalty-free and fully paid-up.

 

2.7           Retained
Rights. The Parties acknowledge and agree that no title, interest or license to any Patent Rights or other Intellectual Property
Rights is granted to HPX Delaware by this Agreement, by implication or otherwise, except as set forth in Section 2.1.

 

2.8           Patent
Marking. HPX Delaware agrees to comply or cause a Third Party to comply with all applicable patent marking statutes in each country
within the Territory in which a Licensed Product is made, offered for sale, sold or imported by HPX Delaware, its Affiliates, licensees
and/or sublicensees.

 

2.9           Bankruptcy.
The Licensed Technology is “intellectual property” as defined in 11 U.S.C. 101(35A) which has been licensed hereunder in
a contemporaneous exchange for value and this Agreement will be governed by 11 U.S.C. 365(n) (and any similar laws in other countries),
as the same may be amended or supplemented from time to time, if I-Pulse files for bankruptcy.

 

	3.	Development and Commercialization of Licensed Products.

 

3.1           Commercialization.
On and after the date hereof, HPX Delaware shall have full control and authority over all commercialization of Licensed Products in the
Licensed Field throughout the Territory, including without limitation: (a) all activities relating to the manufacture and supply of the
Licensed Products; (b) all marketing, promotion, sales, distribution, import and export activities relating to the Licensed Products;
and (c) all activities relating to any regulatory filings, registrations, applications and Regulatory Approvals relating to any of the
foregoing (save as hereinafter set forth, and save that all of the actions provided in this item (c) shall be at the sole cost and expense
of HPX Delaware). HPX Delaware shall own all data, results and all other information arising from any such activities under this Agreement,
including, without limitation, all regulatory filings, registrations, applications and Regulatory Approvals relating to Licensed Products,
and all of the foregoing information, documentation and materials shall be considered Confidential Information owned solely by HPX Delaware.

 

    5

     

    

 

3.2           No Obligation to Commercialize. It is hereby acknowledged and agreed that notwithstanding any and all rights herein granted
to HPX Delaware pursuant to the License, HPX Delaware shall have no obligation whatsoever to exercise any such rights, and for greater
certainty but without limiting the generality of the foregoing, HPX Delaware shall have no obligation to develop, commercialize, sell
or otherwise deal with any of the Licensed Technology or any Licensed Products, the whole without in any way affecting, limiting or jeopardizing
any of the rights herein granted to HPX Delaware.

 

	4.	Intellectual Property Rights.

 

4.1
         Patent Filing Prosecution and Maintenance.

 

(a)   
Patent Rights. As between the Parties, I-Pulse shall have the sole right to prepare, file, prosecute, obtain and maintain,
and acting through patent attorneys or agents of its choice, at its sole cost and expense, all Patent Rights in the Licensed Patents in
all jurisdictions throughout the Territory. In the event that I-Pulse shall fail or refuse to pursue any such prosecution, maintenance,
obtainment, filing, continuation or otherwise within the Licensed Field with respect to the Patent Rights, then HPX Delaware may act to
do so on its own behalf, but for the benefit of and in the name of I-Pulse, at the sole cost and expense of I-Pulse who irrevocably undertakes
to, and shall, fully indemnify and reimburse HPX Delaware for all of its costs and expenses in relation thereto, including, without limitation,
legal fees. Except as explicitly set forth above, for the avoidance of doubt, I-Pulse shall have all rights to prepare, file, prosecute,
obtain and maintain, and acting through patent attorneys or agents of its choice, at its sole cost and expense, all Patent Rights, in
and to all Improvements in all jurisdictions in the Territory.

 

(b)    I-Pulse
Improvements. I-Pulse shall have the right to prepare, file, prosecute, obtain and maintain and acting through patent attorneys
or agents of its choice, at its sole cost and expense, all Patent Rights, in and to all I-Pulse Improvements in the Territory.
I-Pulse: (i) will provide HPX Delaware with a description of any invention included in any I-Pulse Improvements with respect to
which I-Pulse intends to file a patent application, and a copy of any application relating to Patent Rights and/or relating to the
Licensed Field, for review and comment reasonably in advance of filing, which shall under no circumstances be less than thirty (30)
days; and (ii) will keep HPX Delaware reasonably informed of the status of such filing, prosecution and maintenance, including,
without limitation: (x) by providing HPX Delaware with copies of all material communications received from or filed in patent
office(s) with respect to such filing; and (y) by providing HPX Delaware, within a reasonable time prior to taking or failing to
take any action that would materially affect the scope or validity of any such filing (including the substantial narrowing,
cancellation or abandonment of any claim(s) without retaining the right to pursue such subject matter in a separate application, or
the failure to file or perfect the filing of any claim(s) in any country with respect to which I-Pulse notified HPX Delaware that it
intended to file a patent application as set forth above in this Section 4.1(b)), with prior written notice of such proposed
action or inaction so that HPX Delaware has a reasonable opportunity to review and comment. I-Pulse hereby irrevocably agrees to
grant to HPX Delaware for no additional consideration, an exclusive and for the lifetime of the Licensed Patents, including any New Patents
that issue pursuant to this Section 4.1(b), and perpetual, with respect to
Intellectual Property Rights that are not covered by Licensed Patents, including New Patents (subject to the provisions of Section
8 hereof), license in the tenor and breadth of the License, in the Territory, with respect to the Licensed Field, to all I-Pulse
Improvements and I-Pulse shall promptly execute any and all documentation required in order to evidence the same. In addition,
I-Pulse shall be responsible for using commercially reasonable efforts to develop I-Pulse Improvements, including, but not limited
to, the reasonable costs thereof.

 

    6

     

    

 

(c) HPX Delaware
Improvements. HPX Delaware hereby agrees to assign, and hereby assigns to I-Pulse, and I-Pulse accepts the assignment of, all rights,
titles and interests to any Improvements, including all Intellectual Property Rights, it creates, or has created prior to the date hereof,
related to the Licensed Technology and/or Licensed Products (“HPX Delaware Improvements”). HPX Delaware: (i)
will provide I-Pulse with a detailed written description of any Improvements included in any HPX Delaware Improvements with respect to
the Licensed Technology and/or relating to the Licensed Field; and (ii) will provide I-Pulse with all necessary assistance to allow I-Pulse
to perfect Patent Rights and other Intellectual Property Rights in the HPX Delaware Improvements including, but not limited to: (x) providing
I-Pulse with copies of all material communications and documentation relating to the HPX Delaware Improvements; and (y) providing I-Pulse
and I-Pulse’s designated attorneys or agents with access to all inventors of the HPX Delaware Improvements and causing said inventors
to cooperate with all portions of any patent prosecution process or the subsequent enforcement of any Patent Rights, including, but not
limited to, HPX Delaware doing all acts requested by I-Pulse to evidence, apply for, procure, register, record, maintain, enforce and
defend I-Pulse’s rights in and to the same on a prompt basis but in any event within such time periods required for I-Pulse to timely
preserve or assert its rights in any country. HPX Delaware hereby appoints I-Pulse as its agent and attorney-in-fact to act for and on
its behalf in connection with the foregoing, which appointment is irrevocable and coupled with an interest. HPX Delaware acknowledges
and agrees that it has an affirmative obligation to document and promptly identify to I-Pulse any HPX Delaware Improvements and to maintain
the confidentiality of all HPX Delaware Improvements.

 

4.2           Ownership.
HPX Delaware agrees that, as between the Parties, I-Pulse (and/or its Affiliates or related entities, other than HPX Delaware and
its subsidiaries, as applicable) shall own all rights, titles and interests, including, without limitation, all Intellectual
Property Rights, in the Licensed Technology and the Improvements (collectively, “I-Pulse Property”). If
the foregoing is not adequate to vest sole and exclusive ownership of such rights, as between the Parties, in I-Pulse by operation
of law in any jurisdiction, HPX Delaware agrees and hereby does assign, grant and convey all ownership rights in the I-Pulse
Property to I-Pulse effective as of/from the moment of its creation without the necessity of any other action by, or consideration
from, any of the Parties. I-Pulse accepts such assignment, grant and conveyance. HPX Delaware agrees to provide I-Pulse all
assistance required to vest or perfect I-Pulse’s exclusive ownership of the same and to cooperate with I-Pulse and do all acts
requested by I-Pulse to evidence, establish, apply for, procure, register, record, maintain, enforce and defend I-Pulse’s
ownership rights on a prompt basis, but in any event within such time period(s) as required to enable I-Pulse to timely preserve or
assert its rights in any country or region of the world. HPX Delaware agrees to comply with all reasonable requests from I-Pulse
related to securing, protecting, enforcing and defending I- Pulse’s rights in the I-Pulse Property, including, without
limitation, executing additional documents and/or instruments as reasonably requested. HPX Delaware represents and warrants that HPX
Delaware has the right to grant the foregoing rights. HPX Delaware shall promptly make a complete written disclosure to I-Pulse of
each invention, technique, device, method, discovery or procedure, whether patentable or not, conceived or first actually reduced to
practice, solely or jointly by HPX Delaware and/or I-Pulse and/or their respective employees and agents, as a result of this
Agreement and License. HPX Delaware shall specifically point out the features or concepts which HPX Delaware believes to be new or
different. HPX Delaware acknowledges and agrees that HPX Delaware is not granted any rights under any of I-Pulse’s, or its
Affiliates’ or related entities’ (other than HPX Delaware and its subsidiaries), Intellectual Property Rights or other
rights, unless I-Pulse or an Affiliate or a related entity (other than HPX Delaware and its subsidiaries) expressly grants HPX
Delaware such rights in writing. All rights not so expressly granted are hereby expressly reserved to I-Pulse and its Affiliates and
related entities, other than HPX Delaware and its subsidiaries. HPX Delaware further acknowledges and agrees that all HPX Delaware
Improvements shall constitute I-Pulse Property.

 

    7

     

    

 

 4.3           Infringement of Licensed Patent Rights.

 

(a)   
Notice of Infringement. If either Party learns of any actual, alleged or threatened infringement or misappropriation by
a Third Party of any Licensed Technology under this Agreement, such Party shall promptly notify the other Party and shall provide such
other Party with available evidence of such infringement or misappropriation.

 

(b)   Infringement of Licensed Patents. As between the Parties, I-Pulse shall have the obligation, at its own expense and with
legal counsel of its own choice, to bring suit (or take other appropriate legal action) against any actual, alleged or threatened infringement
of the Licensed Patent Rights in the Licensed Patents, and the sole right in its discretion with respect to all other Intellectual Property
Rights. HPX Delaware shall have the right, at its own expense, to participate in any such action brought by I-Pulse that relates to the
Licensed Field using counsel of HPX Delaware’s own choice. If I-Pulse does not file any action or proceeding against such infringement
of a Licensed Patent Right within one (1) month (or such earlier period in the event that HPX Delaware would otherwise be prejudiced)
after the earlier of: (i) I-Pulse’s notice to HPX Delaware under Section 4.3(a) above; or (ii) a written request from HPX
Delaware to take action with respect to such infringement, then HPX Delaware shall have the right (but not the obligation), at its own
expense, to bring suit (or take other appropriate legal action) against such actual, alleged or threatened infringement, with legal counsel
of its own choice.

 

(c)   
Join in Action. If a Party brings any such action or proceeding hereunder, the other Party agrees to be joined as party
plaintiff if necessary to prosecute such action or proceeding, and to give the Party bringing such action or proceeding reasonable assistance
and authority to file and prosecute the suit; provided, however, that neither Party shall be required to transfer any right, title or
interest in or to any property to the other Party or any Third Party to confer standing on a Party hereunder.

 

4.4
          Allocation of Amounts Recovered. Any damages, monetary awards
or other amounts recovered, whether by judgment or settlement, pursuant to any suit, proceeding or other legal action taken under Section
4.3, shall be applied as follows:

 

(a)   
First, to reimburse the Parties for their respective costs and expenses (including reasonable attorneys’ fees and costs)
incurred in prosecuting (or participating with the prosecuting Party in) such enforcement action;

 

(b)   
Second, to HPX Delaware in reimbursement for lost sales (actual and anticipated) associated with Licensed Products;

 

(c)   
Third, to I-Pulse for lost sales (actual and anticipated) associated with any products or services not constituting Licensed Products;
and

 

    8

     

    

 

(d)   
Fourth, any amounts remaining shall be allocated as follows: (x) if I-Pulse or HPX Delaware is the Party bringing such suit or
proceeding or taking such other legal action, one hundred percent (100%) to such Party; and (y) if such suit is brought jointly, fifty
percent (50%) to each Party.

 

4.5
           Defense of Third Party Claim. If any Third Party institutes an action or proceeding against either Party based on a Claim
that the Licensed Technology or a Licensed Product infringes or will infringe any Third Party Intellectual Property Rights, I-Pulse shall
be obliged, at its own expense and with legal counsel of its own choice, to defend (or take other appropriate legal action) against such
action or proceeding; provided, however, that I-Pulse shall: (a) promptly notify HPX Delaware in writing of such action or proceeding
received by it and all prior related Claims; (b) give HPX Delaware the right to participate in the defense and all negotiations for the
settlement or compromise of such action or proceeding that relates to the Licensed Field; provided, further, that HPX Delaware shall provide
to I- Pulse all available information and such assistance and authority as I-Pulse may reasonably require in order to prepare a proper
defense of such action or proceeding. For greater certainty, this Section 4.5 shall be without prejudice to HPX Delaware’s
rights and recourses against I-Pulse for any breach of a representation or warranty of I-Pulse, any material breach of this Agreement
by I-Pulse or any indemnification obligation of I-Pulse hereunder.

 

	5.	Confidential Information.

 

5.1          
Protection of Confidential Information. For the purposes of this Section 5, “Confidential Information”
means all information of a confidential nature disclosed by whatever means by or on behalf of one Party (the “Disclosing Party”)
to the other Party (the “Receiving Party”) and includes the provisions and subject matter of this Agreement.
In connection with the foregoing, the following obligations and responsibilities will apply to all such Confidential Information:

 

(a)   
The Receiving Party is authorized to possess and use Confidential Information only if and to the limited extent necessary, and
only for so long as may be required, in connection with its rights and obligations under this Agreement and no other right of any kind
in or to any of the Confidential Information is granted or conferred upon the Receiving Party;

 

(b)   
The Receiving Party agrees to take all steps reasonably necessary to maintain the Confidential Information in strict confidence
for the benefit of the Disclosing Party, and will not at any time, without the express written permission of the Disclosing Party, disclose
the Confidential Information directly or indirectly to any Person, other than the Receiving Party’s employees, agents or contractors
having a need to know in connection with its rights and obligations under this Agreement (but only if the Receiving Party has first taken
appropriate action, whether by oral or written communications or by agreement or otherwise, to cause such person(s) to observe the obligations
and responsibilities specified in this Agreement); and

 

(c)    Promptly
upon the termination of this Agreement, or at such earlier time as the Disclosing Party may notify the Receiving Party in writing,
the Receiving Party shall: (i) return to the Disclosing Party (or, if so authorized by the Disclosing Party, destroy) all
Confidential Information obtained from the Disclosing Party, together with any copies, extracts or reproductions thereof in any form
whatsoever; (ii) surrender to the Disclosing Party (or at the option of the Disclosing Party, destroy) any working papers or other
documents or tangible manifestation prepared by or for the use of the Receiving Party which are based upon or which contain,
describe or otherwise reveal, in whole or in part, any Confidential Information; and (iii) delete and erase (or cause to be deleted
and erased) from the computers, computer files, retrieval systems, databases, storage media and memory devices of the Receiving
Party all copies and versions of any of the foregoing.

 

    9

     

    

 

5.2          
Exclusions. Section 5.1 shall not apply to the disclosure of Confidential Information if and to the extent: (a) such
disclosure is required by law or in order to enforce any rights pursuant to this Agreement in legal proceedings; or (b) such disclosure
is required by any competent regulatory authority including without limitation, any stock exchange; or (c) such information was obtained
from a Third Party lawfully possessed of such information and not in violation of any confidentiality restrictions or is in the public
domain other than through breach of this clause, provided that any Confidential Information shall only be disclosed after notification
to the other Party to the extent permitted by applicable law.

 

5.3           Equitable
Relief. The Parties acknowledge that the breach or non-performance by the Receiving Party of its responsibilities and obligations
specified in this Section 5 would cause the Disclosing Party immediate and irreparable harm for which monetary damages alone would
not be an adequate remedy. Accordingly, if any such non-performance or breach by the Receiving Party occurs, or is threatened or anticipated
to occur, the Parties agree that the Disclosing Party will be entitled to seek, in addition to any other remedies, specific performance
and/or injunctive relief, and the Receiving Party will not oppose any such application, or require the Disclosing Party to post a bond
or other security (even if otherwise normally required).

 

	6.	Representations and Warranties.

 

6.1          
I-Pulse Representations. I-Pulse hereby represents and warrants to HPX Delaware that the following representations and warranties
are true and correct and acknowledges that HPX Delaware is relying on such representations and warranties in entering into this Agreement:

 

(a)   I-Pulse
is duly constituted, validly existing and in good standing under the laws of its constituting jurisdiction and has full power and authority
under all applicable laws to own its property and to carry on its affairs as they are presently conducted;

 

(b)   The
execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized by all
appropriate corporate action of I-Pulse;

 

(c)   This Agreement constitutes a legal, valid and binding obligation of I-Pulse, enforceable against I-Pulse in accordance with its
terms (except as such enforcement may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, or similar
laws related to or limiting creditors’ rights generally or general principles of equity). None of the execution and delivery of,
and the performance by I-Pulse of any covenant or obligation under this Agreement, contravenes, results in or will contravene, violate
or result in (with or without the giving of notice or lapse of time, or both) any breach or default of, or acceleration of any obligation
of I-Pulse under any applicable law or any agreement to which it is a party;

 

(d)   To
the best of I-Pulse’s knowledge and belief, there are no liens, hypothecs, mortgages, charges, security interests or other encumbrances
on or affecting the Licensed Technology licensed hereunder;

 

(e)   To
the best of I-Pulse’s knowledge and belief, there are no Claims by Third Parties relating to the Licensed Technology licensed hereunder,
nor any violations, infringements or misappropriations of any Third Party’s rights by the Licensed Technology licensed hereunder;

 

    10

     

    

 

(f)    To
the best of I-Pulse’s knowledge and belief, there are no Claims, problems or challenges with respect to the patentability, enforceability
or validity, as applicable, of the Licensed Patents;

 

(g)   To the best of I-Pulse’s knowledge and belief, there are no liabilities whatsoever with respect to the Licensed Patents of
any kind other than the due and punctual payment of patent fees;

 

(h)   To the best of I-Pulse’s knowledge and belief, neither I-Pulse nor the Licensed Technology licensed hereunder are subject
to any restriction imposed by any Governmental Authority or subject to any applicable law, other than applicable patent and intellectual
property law, which restricts or interferes with the transactions contemplated herein, and to the extent any approvals or consents are
required from any Governmental Authority will make reasonable efforts to so obtain;

 

(i)    To
the best of I-Pulse’s knowledge and belief, there is no Claim, demand, suit, action, cause of action, dispute, proceeding, litigation,
investigation, grievance, arbitration, government proceeding or other proceeding, including appeals and applications for review, whether
or not insured, in progress against, by, relating to or affecting the Licensed Technology licensed hereunder, nor are any of the same
pending or threatened. There is not at present outstanding against I-Pulse any order of any Governmental Authority that adversely affects
the Licensed Technology licensed hereunder in any way that relates to this Agreement;

 

(j)    Schedule
I sets forth a list of Licensed Patents owned or licensed by I-Pulse which are related to the development of the Licensed Products.
To the best of I-Pulse’s knowledge and belief, no Intellectual Property Rights of any Third Party whatsoever are in any way incorporated
or included in, or related to, the Licensed Patent Rights or which may have any adverse effect on the Licensed Patent Rights;

 

6.2         HPX
Delaware Representations. HPX Delaware represents and warrants to I-Pulse that the following representations and warranties are
true and correct and acknowledges that I-Pulse is relying on such representations and warranties in entering into this
Agreement:

 

(a)   HPX Delaware is duly constituted, validly existing and in good standing under the laws of its jurisdiction of constitution and
has full power and authority under applicable corporate law to own its property and to carry on its affairs as they are presently conducted;

 

(b)   The
execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized by all
appropriate corporate action of HPX Delaware; and

 

(c)   This Agreement constitutes a legal, valid and binding obligation of HPX Delaware, enforceable against HPX Delaware in accordance
with its terms (except as such enforcement may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization,
or similar laws related to or limiting creditors’ rights generally or general principles of equity). The execution, delivery and
performance of this Agreement by HPX Delaware does not conflict with any agreement, instrument or understanding to which HPX Delaware
is a party or by which it is bound.

 

    11

     

    

 

	7.	Indemnification.

 

7.1           I-Pulse
Indemnity. Subject to the provisions of Section 4.5 hereof, I-Pulse shall, and hereby irrevocably undertakes to,
indemnify, defend and hold harmless HPX Delaware, its Affiliates and Sublicensees and their respective directors, officers,
employees, and agents, and their respective successors, heirs and assigns, from and against any Losses suffered or incurred by any
one or more of them, as a result of, based upon, or arising in connection, directly or indirectly, with: (a) any Claim the Licensed
Technology hereunder infringes the Intellectual Property Rights of a Third Party; (b) any breach of, or falsity or inexactitude in,
any representation or warranty made or given by I-Pulse in this Agreement; (c) any failure by I-Pulse (or any of its Affiliates) to
duly and punctually perform any covenant or obligation contained in this Agreement or in any document delivered pursuant to it; or
(d) the gross negligence of I-Pulse.

 

7.2
          HPX Delaware Indemnity. HPX Delaware shall indemnify,
defend and hold harmless I- Pulse, its Affiliates and their respective directors, officers, employees, and agents, and their
respective successors, heirs and assigns, from and against any Losses suffered or incurred by any one or more of them, as a result
of, based upon, or arising in connection, directly or indirectly, with: (a) any Claim that the Licensed Technology, or a Licensed
Product infringe the Intellectual Property Rights of a Third Party to the extent caused by HPX Delaware’s modifications
thereof; (b) any breach of, or falsity or inexactitude in, any representation or warranty made or given by HPX Delaware in this
Agreement; (c) any failure by HPX Delaware (or any of its Affiliates) to duly and punctually perform any covenant or obligation
contained in this Agreement or in any document delivered pursuant to it; or (d) the gross negligence of HPX Delaware.

 

7.3
           Notice of Claim / Reasonable Assistance. The right of
each of the foregoing Parties to receive indemnification pursuant to this Section 7 is subject to that Party providing prompt
written notice of a claim of indemnification to the Party having an obligation to indemnify pursuant to this Section 7 and
providing reasonable assistance requested by such Party in connection with such claim.

 

	8.	Term and Termination.

 

8.1          Term.
Unless terminated pursuant to this Section 8, this Agreement and the License (subject to
the limitations herein with respect to the Licensed Patents) herein granted shall remain in full force and effect in perpetuity
(“Term”).

 

8.2           Termination
by HPX Delaware. HPX Delaware may terminate this Agreement in its sole discretion at any time during the Term hereof on not less
than one hundred twenty (120) days prior written notice to I-Pulse.

 

8. 3          Termination
by Either Party.

 

(a)   Termination
for Breach. In the event either Party shall be in breach of any material obligation hereunder, the non-breaching Party may give
written notice to the breaching Party specifying the claimed particulars of such breach, and in the event such material breach is
not cured, or effective steps to cure such material breach have not been initiated or are not thereafter diligently pursued within
one hundred and twenty (120) days following the date of such written notification, and, if so initiated and pursued, is not cured
within one hundred and eighty (180) days of such written notification, in addition to any other damages or remedies available to the
non-breaching Party, the non-breaching Party shall have the right thereafter to terminate this Agreement by giving not less than
thirty (30) days prior written notice to the breaching Party to such effect. Any termination by any Party under this Section
8.3(a) shall be without prejudice to any damages or remedies to which it may be entitled from the other Party.

 

    12

     

    

 

(b)   Termination
for Insolvency. Either Party may terminate this Agreement without notice if the other Party becomes insolvent, makes or has made
an assignment for the benefit of creditors, is the subject of proceedings in voluntary or involuntary bankruptcy instituted on behalf
of or against such Party (except for involuntary bankruptcies which are dismissed within ninety (90) days), or has a receiver or trustee
appointed for substantially all of its property.

 

8.4           Effect
of Termination. Upon termination of this Agreement by HPX Delaware pursuant to Section 8.2 or 8.3(b), and upon
termination of this Agreement by I-Pulse pursuant to Section 8.3, all rights and obligations under this Agreement shall
terminate (except as provided in Section 8.5) and all license rights shall revert to I-Pulse and HPX Delaware shall return to
I-Pulse all of I-Pulse’s Confidential Information, including but not limited to, any Licensed Products.

 

8.5
        Survival. Expiration or termination of this Agreement shall not relieve the
Parties of any obligation accruing prior to such expiration or termination. Without limiting the foregoing, the obligations pursuant
to Sections 1, 2.9 (upon termination of this Agreement by HPX Delaware pursuant
to 8.3(b)), 4, 5, 6, 7, 9, 10 and 11,
shall survive termination of this Agreement.

 

	9.	LIMITED LIABILITY.

 

IN NO EVENT SHALL EITHER PARTY BE
LIABLE, ONE TO THE OTHER, FOR INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES OF ANY KIND ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT,
EXCEPT TO THE EXTENT SUCH DAMAGES: (A) ARE INCLUDED IN AN AWARD AGAINST A PARTY RESULTING FROM A THIRD PARTY CLAIM FOR WHICH SUCH PARTY
IS INDEMNIFIED HEREUNDER; (B) ARE RELATED TO, OR ARISE FROM, PERSONAL INJURY, DEATH OR DAMAGE TO TANGIBLE PROPERTY; OR (C) ARE RELATED
TO OR ARISE FROM WILLFUL OR INTENTIONAL MISCONDUCT.

 

	10.	NO WARRANTIES

 

EXCEPT AS OTHERWISE EXPRESSLY SET
FORTH IN SECTIONS 6.1 OR 6.2, NEITHER PARTY MAKES ANY REPRESENTATION OR EXTENDS ANY WARRANTIES OF ANY KIND, EITHER EXPRESS
OR IMPLIED, TO THE OTHER PARTY, INCLUDING ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

 

	11.	General Provisions.

 

11.1         Notices.
Any notice or document shall be deemed to be given or delivered to or received by a Party (a) if delivered in person, at the time of
delivery, (b) if sent by one Party to another Party within the same jurisdiction, at 10:00 a.m. on the second Business Day (which
for purposes of this Section means a day during which commercial banks in Toronto and New York are generally open for business)
after it was put into the post, or if sent by post by one Party to another Party in a different jurisdiction, at 10:00 a.m. (local
time at the place of destination) on the fifth Business Day after it was put into the post, or (c) if sent by fax, at the expiration
of two hours after the time of dispatch, if dispatched before 3:00 p.m. (local time at the place of destination) on any Business
Day, and in any other case at 10:00 a.m. (local time at the place of destination) on the next Business Day following the date of
dispatch, in each case, to such Party at the first fax number or address listed for such Party below. All notices, requests, claims,
demands and other communications under this Agreement shall be delivered to the Parties in person or sent to the address set forth
below by registered post, postage prepaid and return receipt requested or by facsimile (with confirmation of receipt) as
follows:

 

If to I-Pulse:

 

	 	Attention:	Corporate Secretary
	 	Facsimile No.:	 +1-604-682-2060
	 	Address:	654 – 999 CanadaPlace

                                                         Vancouver, BC V6C 3E1

                                                         Canada

 

If to HPX Delaware:

 

	 	Attention:	Corporate Secretary
	 	Facsimile No.:	 +1-604-682-2060
	 	Address:	654 – 999 CanadaPlace

                                                         Vancouver, BC V6C 3E1

                                                         Canada

  

    13

     

    

 

11.2         Non-Competition. I-Pulse shall not compete directly or indirectly with HPX Delaware in the Territory, including, without
limitation (a) providing any services within the Field of Use to any Third Party, or (b) licensing or sublicensing any Intellectual Property
Rights for use within the Field of Use, which would enable any Third Party to compete with HPX Delaware in the Territory.

 

11.3         Severability. In the event that any provision of this Agreement is determined by a court of competent jurisdiction to be
unenforceable or invalid under any applicable law, such provision will be interpreted in a manner, or replaced by a provision, that, to
the greatest extent possible, effectuates the objectives of such provision within the limits of applicable law or applicable court decisions.
The unenforceability or invalidity of any such provision will in no event affect the validity, force or effect of the remaining provisions
of this Agreement.

 

11.4         Governing Law. Any claims or disputes arising out of or related hereto or to the transactions contemplated hereby or to
the inducement of any Party to enter herein, whether for breach of contract, tortious conduct or otherwise and whether predicated on common
law, statute or otherwise, shall in all respects be governed by and construed in accordance with the laws of the State of New York, including
all matters of construction, validity and performance, in each case without reference to any conflict of law rules that might lead to
the application of the laws of any other jurisdiction.

 

11.5         Venue.
Any suit or action of any kind brought to enforce any provision of this Agreement shall be brought in any court of competent jurisdiction
in the County of New York, State of New York, United States. The Parties consent to personal jurisdiction of and venue in the state and
federal courts within that county and hereby irrevocably waive any objections to such jurisdiction, including but not limited to the
laying of venue or based on the grounds of forum non conveniens, which it may now or hereafter have to the bringing of any such action
or proceeding in such respective jurisdictions. Each of the Parties hereto hereby irrevocably consents to the service of process of any
of the aforementioned courts in any such action or proceeding by the means set out for the giving of notice pursuant to Section 11.1
of this Agreement. Nothing herein shall affect the right of any Party hereto to serve process in any other manner permitted by law.

 

    14

     

    

 

11.6         Entire
Agreement. This Agreement, together with the Schedules and other attachments hereto, contains the entire understanding between the
Parties with respect to the subject matter hereof and supersedes all prior agreements, understandings and negotiations with respect to
the subject matter hereof.

 

11.7         Amendment.
This Agreement may be amended only by an instrument in writing signed by all of the Parties.

 

11.8         No
Waiver. No omission or delay on the part of any Party in exercising its rights under this Agreement or in requiring due and proper
fulfillment by the other Party as set forth in this Agreement shall be deemed to constitute a waiver and no waiver by the Party of any
breach or default by the other Party shall operate as a waiver of any succeeding breach or other default or breach by the other Party.

 

11.9         Interpretation
and Construction. References to Sections are to the Sections herein. The headings in this Agreement are included for convenience
of reference only and shall not in any way limit or affect the meaning or interpretation of any of the terms hereof. This Agreement
shall not be construed as creating a partnership between the Parties or joint venture of any kind or any other form of legal
association that would impose liability upon one Party for the acts or failure to act of the other Party. Nothing contained herein
will be construed as creating any agency, employment, franchise, partnership or other form of joint enterprise between the Parties.
Neither Party shall have, or hold itself out as having, the right or authority to assume or create any obligation or responsibility,
whether express or implied, on behalf of or in the name of the other, except with the express written consent of the other. Wherever
any words are used herein in the masculine, feminine or neuter gender, they shall be construed as though they were used in another
gender in all cases where they would so apply, and whenever any words are used herein in the singular or plural form, they shall be
construed as though they were also used in the other form in all cases where they would so apply.

 

11.10       Force
Majeure. Neither Party shall be liable for any default or delay in the performance of its obligations under this Agreement to
the extent such default or delay is caused, directly or indirectly, by fire, flood, earthquake, elements of nature or Acts of God;
acts of war, terrorism, riots, civil disorders, rebellions or revolutions; strikes, lockouts or labor difficulties; or any other
similar cause beyond the reasonable control of such Party (a “Force Majeure Event”). These delays shall
not constitute a breach of this Agreement and the non-performing Party will be excused from any further performance or observance of
the obligations so affected by the Force Majeure Event for as long as the Force Majeure Event exists and such Party continues to use
its best efforts to recommence performance or observance thereof whenever and to whatever extent possible without delay. Any Party
so delayed in its performance will immediately notify the other Party by telephone (confirmed in writing within two (2) Business
Days of the inception of such delay).

 

11.11       Execution.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original copy of this Agreement,
and all of which together will constitute one and the same agreement.

 

    15

     

    

 

IN
WITNESS WHEREOF, the Parties hereto, each acting under due and proper authority, have executed this Technology License Agreement
effective as of the day, month and year first above written.

 

	 	I-PULSE INC.
	 	 
	 	By:	/s/ Laurent Frescaline
	 	 	Name:	Laurent Frescaline
	 	 	Title:	CEO
	 	 
	 	HIGH POWER EXPLORATION INC.
	 	 
	 	By:	/s/ Mark Gibson
	 	 	Name:	MARK GIBSON
	 	 	Title:	CHIEF EXECUTIVE OFFICER 

 

    16

     

    

 

SCHEDULE
I

 

Licensed
Patents:

 

National Phase applications entitled
 “Sparkgap device, particularly high-voltage spark-gap device,” resulting from PCT International Patent Application No. PCT/FR
2004/001192, dated May 14, 2004, filed in Australia, Canada, China, South Korea, India, Japan and the United States.

 

All other patents and patent applications
with respect to the Licensed Field, including, for the avoidance of doubt, with respect to the Zeus and Typhoon Transmitters, issued to
I-Pulse, or applied for by, or on behalf of, I-Pulse as of the date hereof. This Schedule I may be amended from time to time by
mutual agreement by notation of the Parties without the need for a formal amendment to this Agreement to further specify such patents
and patent applications.

 

Territory: Worldwide

 

Licensed Field (Fields of Use): Geological
Survey for mineral exploration .

 

    17Exhibit 10.4

 

Execution Copy

 

TECHNOLOGY
LICENSE AGREEMENT

 

THIS TECHNOLOGY
LICENSE AGREEMENT (this “Agreement”) is entered into as of March 23, 2012 by and between High Power Exploration
Inc., a company organized under the laws of the state of Delaware (formerly known as GoviEx IP Holdings Inc. and the assignee of a
patent license from Govi High Power Exploration Inc.) (“HPX Delaware”) and GEO27 S.ar.l., a company organized
under the laws of Luxembourg (“GEO27”), and (each, a “Party,” and collectively, the
 “Parties”).

 

WHEREAS, HPX Delaware is the licensee of the Licensed
Technology (as defined below);

 

WHEREAS,
GEO27 desires to obtain from HPX Delaware, and HPX Delaware is willing to grant to GEO27, an exclusive, and for the lifetime of the Licensed
Patents (all capitalized terms as defined below) and perpetual in the case of the Licensed Technology other than the Licensed Patents
(subject to the termination provisions hereinafter set forth), European Union license for the use of the Licensed Technology within the
Licensed Field and the European Union right to develop and commercialize the Licensed Products, subject to, and in accordance with, the
terms and conditions set forth herein.

 

NOW, THEREFORE,
in consideration of the mutual promises, representations and warranties contained herein, the Parties, intending to be legally bound,
hereby agree as follows:

 

		1.	Definitions.

 

1.1              
“Affiliate” and “Affiliated” means (a) any other Person that, directly or indirectly,
through one or more intermediaries, controls, is controlled by, or is under common control with, such Person, or (b) any other Person,
including but not limited to subsidiaries, of which such Person owns, directly or indirectly, a twenty-five percent (25%) or greater equity
or voting interest. In addition, with respect to a Person that is an individual, “Affiliate” shall also include (x) the immediate
family of such individual, including, without limitation, his or her spouse, children and their spouses, grandchildren and any other descendants
by blood or adoption, and (y) any trust, limited liability company, partnership or other entity the equity owners or beneficiaries (as
applicable) of which are any of the individuals described in the foregoing clause (x). For purposes of clarification, “Affiliate”
of any Person shall also include any other Person that becomes an Affiliate of such Person after the date hereof.

 

1.2              
“Claim” means any demand, investigation, action, suit, proceeding, claim, assessment, judgment, settlement
or compromise relating, directly or indirectly, to: (a) the Licensed Technology, including without limitation the Licensed Patents, any
Patent Rights, Licensed Patent Rights or Licensed Product; and/or (b) this Agreement (including without limitation, the License contained
herein, the obligations of the Parties pursuant hereto and the representations and warranties made by the Parties herein).

 

		1.3	“Confidential Information” has the meaning ascribed thereto in Section 5.1.

 

1.4          
“Control” (including the terms “controlled by” and “under common control with”)
means, with respect to the relationship between or among two or more Persons, the possession, directly or indirectly, of the power to
direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting securities, as trustee
or executor, by contract or otherwise, including, without limitation, the ownership, directly or indirectly, of securities having the
power to elect a majority of directors or similar body governing the affairs of such Person.

 

     

     

    

 

		1.5	“Disclosing Party” has the meaning ascribed thereto in Section 5.1.

 

		1.6	“Force Majeure Event” has the meaning ascribed thereto in Section 11.10.

 

1.7          
“Governmental Authority” means any domestic or foreign, federal, national, state, multi- state, international,
multinational or municipal or other local government, any subdivision, agency, commission or authority thereof, or any quasi-governmental
or private body exercising any regulatory or taxing authority thereunder or any court or other tribunal or judicial authority.

 

		1.8	“GEO27 Improvements” has the meaning ascribed thereto in Section 4.1(c).

 

1.9          
“Improvements” means any enhancement, invention, variation, update, modification or discovery created,
identified or discovered by or on behalf of either Party with respect, directly or indirectly, to the subject matter of the Licensed Technology.

 

1.10        
“Intellectual Property Rights” means (a) all rights under all copyright laws of the United States and
all other countries for the full terms thereof (of all rights accruing by virtue of copyright treaties and conventions), including but
not limited to all renewals, extensions, reversions or restorations of copyrights now or hereafter provided by law and all rights to make
applications for and obtain copyright registrations therefor and recordations thereof, and including without limitation all copyright
rights in all software, documentation, user and application interfaces including without limitation the look and feel and the structure,
sequence and organization thereof; (b) all rights to and under new and useful inventions, discoveries, designs, technology and art and
all other patentable subject matter, including, but not limited to, all improvements thereof and all know-how related thereto, and all
applications for and the right to make applications for Letters Patent in the United States and all other countries, all Letters Patents
that issue therefrom and all reissues, extensions, renewals, divisions and continuations (including continuations-in-part) thereof, for
the full term thereof; (c) all trademarks, service marks and Internet domain names and the like and the goodwill associated therewith
throughout the world; (d) all trade secrets, confidential business information, evaluations and reports; (e) all know-how under the laws
of any jurisdiction and all know-how not otherwise included in the foregoing; and (f) all other intellectual and industrial property and
proprietary rights throughout the world not otherwise included in the foregoing, including without limitation all techniques, methodologies
and concepts and trade dress.

 

1.11        
“HPX Delaware Improvements” means any enhancement, invention, variation, update, modification or discovery
created, identified or discovered by or on behalf of HPX Delaware or otherwise acquired by HPX Delaware with respect, directly or indirectly,
to the subject matter of the Licensed Technology in the Licensed Field.

 

		1.12	“License” has the meaning ascribed thereto in Section 2.1.

 

1.13        
“Licensed Field” and “Field of Use” mean the use of the Licensed Technology
for any purpose in the fields listed in Schedule I.

 

1.14        
“Licensed Patents” means those patents and patent applications identified in Schedule I hereto
and any New Patents, and any Patent Rights, if any, of HPX Delaware throughout the Territory with respect to the Licensed Field.

 

		1.15	“Licensed Patent Rights” means all Patent Rights with respect to the Licensed Patents.

 

    2

     

    

 

Execution Copy

 

1.16         “Licensed
Product” means any present or future product or service within the Field of Use, the manufacture, use, offer for sale,
sale or performance of which: (a) incorporates, embodies or otherwise includes any of the Licensed Patents, HPX Delaware
Improvements or related Intellectual Property Rights; or (b) would, absent the license granted to GEO27 hereunder, infringe or
misappropriate any of the Licensed Patent Rights, HPX Delaware Improvements or related Intellectual Property Rights.

 

1.17        
“Licensed Technology” means the Licensed Patents, and all technology or Improvements (including, but
not limited to, any Patent Rights applicable to any such technology or Improvements thereof in whole or in part) developed by HPX Delaware
in the Licensed Field or in connection with, related to, arising from, used in the making of and/or embodied in the Licensed Products
(including, but not limited to, all modifications, additions, enhancements and Improvements of any kind to the Licensed Patents and such
technology) and all other Intellectual Property Rights owned by or licensed to HPX Delaware and associated with the Licensed Patents or
such technology or Improvements during the term of this Agreement. Without limitation of the foregoing, and for the avoidance of doubt,
the foregoing shall include all know-how with respect to the Zeus Transmitter.

 

		1.18	“License Fee” has the meaning ascribed thereto in Section 2.2.

 

1.19        
“Losses” means and includes, but shall not be limited to, losses, liabilities, claims, damages, costs
(including, without limitation, the reasonable costs incurred in the enforcement of any indemnification obligations, or taxes), reasonable
legal fees (including reasonable attorneys’ fees and disbursements and costs of investigation, litigation and settlement), liabilities,
penalties and expenses incurred by the applicable Person.

 

1.20         
“New Patents” mean any patent and patent applications with respect to the HPX Delaware Improvements.

 

1.21        
“Patent Rights” means the rights and interests in and to issued patents and patent applications (including
inventors’ certificates and utility models) in any country or jurisdiction within the Territory, including all substitutions, continuations,
continuations-in-part, divisional applications, supplementary protection certificates, renewals, all Letters Patent granted thereon, and
all reissues, reexaminations, extensions, confirmations, revalidations, registrations, patents of addition and foreign counterparts.

 

1.22        
“Person” means any individual, sole proprietorship, partnership, incorporated organization, association,
corporation, limited liability company, institution, public benefit corporation, any other entity, estate, trust, firm, company, government,
Governmental Authority or any joint venture (whether or not having a separate legal personality).

 

		1.23	“Receiving Party” has the meaning ascribed thereto in Section 5.1.

 

1.24        
“Regulatory Approval” means all technical and other licenses, registrations, authorizations, permits
or approvals (including, without limitation, supplements, amendments, post- approvals, pricing and Third Party reimbursement approvals,
marketing authorizations based on such approvals, including any prerequisite manufacturing approvals or authorizations related thereto
and labeling approvals) of any national, federal, regional, provincial, state or local regulatory agency, department, bureau, commission,
council or other Governmental Authority, necessary for the development, manufacture, distribution, marketing, promotion, commercialization,
offer for sale, use, import, export or sale of the Licensed Products.

 

1.25        
“Sublicensee” means any Third Party to whom GEO27 grants a sublicense of some or all of the rights granted
to GEO27 under this Agreement.

 

		1.26	“Territory” means those countries and/or jurisdictions listed in Schedule I
hereto.

 

     3

     

    

 

1.27         
“Third Party” and “Third Parties” mean one or more Persons other than GEO27,
HPX Delaware and their respective Affiliates.

 

		2.	Grant of Rights.

 

2.1          
License. Subject to the terms and conditions of this Agreement, HPX Delaware hereby grants to GEO27 a royalty-free (subject
to Section 2.2), fully paid-up, exclusive, perpetual (subject to the provisions of Section 8
hereof and as further set forth below), license under all of HPX Delaware’s Intellectual Property Rights within the Licensed Field,
throughout the Territory with respect to the Licensed Technology relating to any Licensed Product, to: (a) make, use, modify, enhance
and develop the Licensed Technology relating to any Licensed Product; and (b) develop, manufacture, promote, market, distribute, sell,
offer for sale and commercialize any and all Licensed Products; notwithstanding the foregoing, the term of the license to the Licensed
Patents incorporated in the Licensed Technology shall be for the terms of the respective Licensed Patents in countries in the Territory
where there are Patent Rights (subject to the provisions of Section 8 hereof), (the “License”).
For the avoidance of doubt, the sole and exclusive nature of the License herein granted being acknowledged, HPX Delaware, including, without
limitation, any transferee, assignee or successor thereof, shall have no right to deal in any way with (or exercise any right herein granted
to GEO27 with respect to) the Licensed Patents or any Licensed Product (including, without limitation, to manufacture, promote, market,
distribute, sell, offer for sale and/or commercialize Licensed Products) within the Licensed Field throughout the Territory, and any such
purported right shall be null and void. The Parties hereby further agree and confirm that the terms and conditions of the License granted
herein, including without limitation the aforesaid exclusivity, shall survive any change in Control of HPX Delaware or the assignment,
transfer or sale of all or substantially all of the assets of HPX Delaware, including, without limitation, any assignment, transfer or
sale of all or substantially all of the assets of HPX Delaware by operation of law or otherwise.

 

2.2           License
Fee. In consideration of the License granted herein, GEO27 shall pay HPX Delaware, within sixty (60) days of the final
determination thereof, a sum equal to the fair market value of the European Union rights, based on a valuation determined by an
independent appraiser agreed to by and among the Parties, to be selected from the following: (i) PricewaterhouseCoopers LLP; (ii)
Ernst & Young LLP; (iii) Deloitte LLP; (iv) KPMG LLP; (v) Duff & Phelps, LLC; (vi) FTI Consulting, Inc.; or (vii) Houlihan
Lokey, Inc. (the “License Fee”).

 

2.3          
Publication Rights. The License granted in Section 2.1 includes the right to disclose or make public any and all
information, including results, based on the work or activities carried out by GEO27 in connection with the development of Licensed Products
or their use within the Licensed Field other than trade secrets, know-how or other confidential or proprietary information with respect
to the Licensed Technology, the Licensed Products, and HPX Delaware’s other business activities outside of the Licensed Field, which
GEO27 shall at all times keep confidential. GEO27 agrees not to disclose any information or make any public statements relating to the
use or application of the Licensed Technology, Licensed Products or the subject technology of the Licensed Technology as related to any
use other than the Licensed Field.

 

2.4          
Recordation. GEO27 and HPX Delaware shall cooperate, at HPX Delaware’s expense, to record this Agreement to the extent,
if any, required by Governmental Authorities in order to establish, perfect or enforce the Parties’ rights hereunder, provided that
the terms of this Agreement shall not be provided or otherwise disclosed except to the extent necessary to effect such recordation.

 

2.5            Right
to Sublicense. GEO27 shall have the unrestricted and unlimited right to grant sublicenses (subject, for the avoidance of doubt,
to the confidentiality provisions hereof) as to all or any portion of its rights under the License granted pursuant to Section
2.1 hereof to any Person as it in its sole discretion desires, provided that GEO27 shall indemnify HPX Delaware for any and all
Claims made against or Losses incurred by HPX Delaware as a direct result of any such sublicense.

 

     4

     

    

 

2.6          
Consideration. Subject to Section 2.2, it is hereby acknowledged that the License granted herein is royalty-free
and fully paid-up.

 

2.7          
Retained Rights. The Parties acknowledge and agree that no title, interest or license to any Patent Rights or other Intellectual
Property Rights is granted to GEO27 by this Agreement, by implication or otherwise, except as set forth in Section 2.1.

 

2.8          
Patent Marking. GEO27 agrees to comply or cause a Third Party to comply with all applicable patent marking statutes in each
country within the Territory in which a Licensed Product is made, offered for sale, sold or imported by GEO27, its Affiliates, licensees
and/or sublicensees.

 

2.9          
Bankruptcy. The Licensed Technology is “intellectual property” as defined in 11 U.S.C. 101(35A) which has been
licensed hereunder in a contemporaneous exchange for value and this Agreement will be governed by 11 U.S.C. 365(n) (and any similar laws
in other countries), as the same may be amended or supplemented from time to time, if HPX Delaware files for bankruptcy.

 

		3.	Development and Commercialization of Licensed Products.

 

3.1          
Commercialization. On and after the date hereof, GEO27 shall have full control and authority over all commercialization
of Licensed Products in the Licensed Field throughout the Territory, including without limitation: (a) all activities relating to the
manufacture and supply of the Licensed Products; (b) all marketing, promotion, sales, distribution, import and export activities relating
to the Licensed Products; and (c) all activities relating to any regulatory filings, registrations, applications and Regulatory Approvals
relating to any of the foregoing (save as hereinafter set forth, and save that all of the actions provided in this item (c) shall be at
the sole cost and expense of GEO27). GEO27 shall own all data, results and all other information arising from any such activities under
this Agreement, including, without limitation, all regulatory filings, registrations, applications and Regulatory Approvals relating to
Licensed Products, and all of the foregoing information, documentation and materials shall be considered Confidential Information owned
solely by GEO27.

 

3.2          
No Obligation to Commercialize. It is hereby acknowledged and agreed that notwithstanding any and all rights herein granted
to GEO27 pursuant to the License, GEO27 shall have no obligation whatsoever to exercise any such rights, and for greater certainty but
without limiting the generality of the foregoing, GEO27 shall have no obligation to develop, commercialize, sell or otherwise deal with
any of the Licensed Technology or any Licensed Products, the whole without in any way affecting, limiting or jeopardizing any of the rights
herein granted to GEO27.

 

		4.	Intellectual Property Rights.

 

		4.1	Patent Filing Prosecution and Maintenance.

 

(a)    Patent
Rights. As between the Parties, HPX Delaware shall have the sole right to prepare, file, prosecute, obtain and maintain, and
acting through patent attorneys or agents of its choice, at its sole cost and expense, all Patent Rights in the Licensed Patents in
all jurisdictions throughout the Territory. In the event that HPX Delaware shall fail or refuse to pursue any such prosecution,
maintenance, obtainment, filing, continuation or otherwise within the Licensed Field with respect to the Patent Rights, then GEO27
may act to do so on its own behalf, but for the benefit of and in the name of HPX Delaware, at the sole cost and expense of HPX
Delaware who irrevocably undertakes to, and shall, fully indemnify and reimburse GEO27 for all of its costs and expenses in relation
thereto, including, without limitation, legal fees. Except as explicitly set forth above, for the avoidance of doubt, HPX Delaware
shall have all rights to prepare, file, prosecute, obtain and maintain, and acting through patent attorneys or agents of its choice,
at its sole cost and expense, all Patent Rights, in and to all Improvements in all jurisdictions in the Territory.

 

     5

     

    

 

(b)   
HPX Delaware Improvements. HPX Delaware shall have the right to prepare, file, prosecute, obtain and maintain and acting
through patent attorneys or agents of its choice, at its sole cost and expense, all Patent Rights, in and to all HPX Delaware Improvements
in the Territory. HPX Delaware: (i) will provide GEO27 with a description of any invention included in any HPX Delaware Improvements with
respect to which HPX Delaware intends to file a patent application, and a copy of any application relating to Patent Rights and/or relating
to the Licensed Field, for review and comment reasonably in advance of filing, which shall under no circumstances be less than thirty
(30) days; and (ii) will keep GEO27 reasonably informed of the status of such filing, prosecution and maintenance, including, without
limitation: (x) by providing GEO27 with copies of all material communications received from or filed in patent office(s) with respect
to such filing; and (y) by providing GEO27, within a reasonable time prior to taking or failing to take any action that would materially
affect the scope or validity of any such filing (including the substantial narrowing, cancellation or abandonment of any claim(s) without
retaining the right to pursue such subject matter in a separate application, or the failure to file or perfect the filing of any claim(s)
in any country with respect to which HPX Delaware notified GEO27 that it intended to file a patent application as set forth above in this
Section 4.1(b)), with prior written notice of such proposed action or inaction so that GEO27 has a reasonable opportunity to review
and comment. HPX Delaware hereby irrevocably agrees to grant to GEO27 for no additional consideration, an exclusive and for the lifetime
of the Licensed Patents, including any New Patents that issue pursuant to this Section 4.1(b), and
perpetual, with respect to Intellectual Property Rights that are not covered by Licensed Patents, including New Patents (subject to the
provisions of Section 8 hereof), license in the tenor and breadth of the License, in the Territory, with respect to the Licensed
Field, to all HPX Delaware Improvements and HPX Delaware shall promptly execute any and all documentation required in order to evidence
the same. In addition, HPX Delaware shall be responsible for using commercially reasonable efforts to develop HPX Delaware Improvements,
including, but not limited to, the reasonable costs thereof.

 

(c)    GEO27
Improvements. GEO27 hereby agrees to assign, and hereby assigns to HPX Delaware, and HPX Delaware accepts the assignment of, all
rights, titles and interests to any Improvements, including all Intellectual Property Rights, it creates, or has created prior to
the date hereof, related to the Licensed Technology and/or Licensed Products (“GEO27 Improvements”).
GEO27: (i) will provide HPX Delaware with a detailed written description of any Improvements included in any GEO27 Improvements with
respect to the Licensed Technology and/or relating to the Licensed Field; and (ii) will provide HPX Delaware with all necessary
assistance to allow HPX Delaware to perfect Patent Rights and other Intellectual Property Rights in the GEO27 Improvements
including, but not limited to: (x) providing HPX Delaware with copies of all material communications and documentation relating to
the GEO27 Improvements; and (y) providing HPX Delaware and HPX Delaware’s designated attorneys or agents with access to all
inventors of the GEO27 Improvements and causing said inventors to cooperate with all portions of any patent prosecution process or
the subsequent enforcement of any Patent Rights, including, but not limited to, GEO27 doing all acts requested by HPX Delaware to
evidence, apply for, procure, register, record, maintain, enforce and defend HPX Delaware’s rights in and to the same on a
prompt basis but in any event within such time periods required for HPX Delaware to timely preserve or assert its rights in any
country. GEO27 hereby appoints HPX Delaware as its agent and attorney-in-fact to act for and on its behalf in connection with the
foregoing, which appointment is irrevocable and coupled with an interest. GEO27 acknowledges and agrees that it has an affirmative
obligation to document and promptly identify to HPX Delaware any GEO27 Improvements and to maintain the confidentiality of all GEO27
Improvements.

 

     6

     

    

 

4.2          
Ownership. GEO27 agrees that, as between the Parties, HPX Delaware (and/or its Affiliates or related entities, other than
GEO27 and its subsidiaries, as applicable) shall own all rights, titles and interests, including, without limitation, all Intellectual
Property Rights, in the Licensed Technology and the Improvements (collectively, “HPX Delaware Property”). If
the foregoing is not adequate to vest sole and exclusive ownership of such rights, as between the Parties, in HPX Delaware by operation
of law in any jurisdiction, GEO27 agrees and hereby does assign, grant and convey all ownership rights in the HPX Delaware Property to
HPX Delaware effective as of/from the moment of its creation without the necessity of any other action by, or consideration from, any
of the Parties. HPX Delaware accepts such assignment, grant and conveyance. GEO27 agrees to provide HPX Delaware all assistance required
to vest or perfect HPX Delaware’s exclusive ownership of the same and to cooperate with HPX Delaware and do all acts requested by
HPX Delaware to evidence, establish, apply for, procure, register, record, maintain, enforce and defend HPX Delaware’s ownership
rights on a prompt basis, but in any event within such time period(s) as required to enable HPX Delaware to timely preserve or assert
its rights in any country or region of the world. GEO27 agrees to comply with all reasonable requests from HPX Delaware related to securing,
protecting, enforcing and defending HPX Delaware’s rights in the HPX Delaware Property, including, without limitation, executing
additional documents and/or instruments as reasonably requested. GEO27 represents and warrants that GEO27 has the right to grant the foregoing
rights. GEO27 shall promptly make a complete written disclosure to HPX Delaware of each invention, technique, device, method, discovery
or procedure, whether patentable or not, conceived or first actually reduced to practice, solely or jointly by GEO27 and/or HPX Delaware
and/or their respective employees and agents, as a result of this Agreement and License. GEO27 shall specifically point out the features
or concepts which GEO27 believes to be new or different. GEO27 acknowledges and agrees that GEO27 is not granted any rights under any
of HPX Delaware’s, or its Affiliates’ or related entities’ (other than GEO27 and its subsidiaries), Intellectual Property
Rights or other rights, unless HPX Delaware or an Affiliate or a related entity (other than GEO27 and its subsidiaries) expressly grants
GEO27 such rights in writing. All rights not so expressly granted are hereby expressly reserved to HPX Delaware and its Affiliates and
related entities, other than GEO27 and its subsidiaries. GEO27 further acknowledges and agrees that all GEO27 Improvements shall constitute
HPX Delaware Property.

 

		4.3	Infringement of Licensed Patent Rights.

 

(a)   
Notice of Infringement. If either Party learns of any actual, alleged or threatened infringement or misappropriation by
a Third Party of any Licensed Technology under this Agreement, such Party shall promptly notify the other Party and shall provide such
other Party with available evidence of such infringement or misappropriation.

 

(b)    Infringement
of Licensed Patents. As between the Parties, HPX Delaware shall have the obligation, at its own expense and with legal counsel
of its own choice, to bring suit (or take other appropriate legal action) against any actual, alleged or threatened infringement of
the Licensed Patent Rights in the Licensed Patents, and the sole right in its discretion with respect to all other Intellectual
Property Rights. GEO27 shall have the right, at its own expense, to participate in any such action brought by HPX Delaware that
relates to the Licensed Field using counsel of GEO27’s own choice. If HPX Delaware does not file any action or proceeding
against such infringement of a Licensed Patent Right within one (1) month (or such earlier period in the event that GEO27 would
otherwise be prejudiced) after the earlier of: (i) HPX Delaware’s notice to GEO27 under Section 4.3(a) above; or (ii) a
written request from GEO27 to take action with respect to such infringement, then GEO27 shall have the right (but not the
obligation), at its own expense, to bring suit (or take other appropriate legal action) against such actual, alleged or threatened
infringement, with legal counsel of its own choice.

 

     7

     

    

 

(c)   
Join in Action. If a Party brings any such action or proceeding hereunder, the other Party agrees to be joined as party
plaintiff if necessary to prosecute such action or proceeding, and to give the Party bringing such action or proceeding reasonable assistance
and authority to file and prosecute the suit; provided, however, that neither Party shall be required to transfer any right, title or
interest in or to any property to the other Party or any Third Party to confer standing on a Party hereunder.

 

4.4  
Allocation of Amounts Recovered. Any damages, monetary awards or other amounts recovered, whether by judgment or settlement,
pursuant to any suit, proceeding or other legal action taken under Section 4.3, shall be applied as follows:

 

(a)   
First, to reimburse the Parties for their respective costs and expenses (including reasonable attorneys’ fees and costs)
incurred in prosecuting (or participating with the prosecuting Party in) such enforcement action;

 

(b)   
Second, to GEO27 in reimbursement for lost sales (actual and anticipated) associated with Licensed Products;

 

(c)   
Third, to HPX Delaware for lost sales (actual and anticipated) associated with any products or services not constituting Licensed
Products; and

 

(d)   
Fourth, any amounts remaining shall be allocated as follows: (x) if HPX Delaware or GEO27 is the Party bringing such suit or proceeding
or taking such other legal action, one hundred percent (100%) to such Party; and (y) if such suit is brought jointly, fifty percent (50%)
to each Party.

 

4.5  
Defense of Third Party Claim. If any Third Party institutes an action or proceeding against either Party based on a Claim
that the Licensed Technology or a Licensed Product infringes or will infringe any Third Party Intellectual Property Rights, HPX Delaware
shall be obliged, at its own expense and with legal counsel of its own choice, to defend (or take other appropriate legal action) against
such action or proceeding; provided, however, that HPX Delaware shall: (a) promptly notify GEO27 in writing of such action or proceeding
received by it and all prior related Claims; (b) give GEO27 the right to participate in the defense and all negotiations for the settlement
or compromise of such action or proceeding that relates to the Licensed Field; provided, further, that GEO27 shall provide to HPX Delaware
all available information and such assistance and authority as HPX Delaware may reasonably require in order to prepare a proper defense
of such action or proceeding. For greater certainty, this Section 4.5 shall be without prejudice to GEO27’s rights and recourses
against HPX Delaware for any breach of a representation or warranty of HPX Delaware, any material breach of this Agreement by HPX Delaware
or any indemnification obligation of HPX Delaware hereunder.

 

     8

     

    

 

		5.	Confidential Information.

 

5.1   Protection
of Confidential Information. For the purposes of this Section 5, “Confidential Information” means all
information of a confidential nature disclosed by whatever means by or on behalf of one Party (the “Disclosing
Party”) to the other Party (the “Receiving Party”) and includes the provisions and subject
matter of this Agreement.In connection with the foregoing, the following obligations and responsibilities will apply to all such
Confidential Information:

 

(a)   
The Receiving Party is authorized to possess and use Confidential Information only if and to the limited extent necessary, and
only for so long as may be required, in connection with its rights and obligations under this Agreement and no other right of any kind
in or to any of the Confidential Information is granted or conferred upon the Receiving Party;

 

(b)   
The Receiving Party agrees to take all steps reasonably necessary to maintain the Confidential Information in strict confidence
for the benefit of the Disclosing Party, and will not at any time, without the express written permission of the Disclosing Party, disclose
the Confidential Information directly or indirectly to any Person, other than the Receiving Party’s employees, agents or contractors
having a need to know in connection with its rights and obligations under this Agreement (but only if the Receiving Party has first taken
appropriate action, whether by oral or written communications or by agreement or otherwise, to cause such person(s) to observe the obligations
and responsibilities specified in this Agreement); and

 

(c)    Promptly
upon the termination of this Agreement, or at such earlier time as the Disclosing Party may notify the Receiving Party in writing,
the Receiving Party shall: (i) return to the Disclosing Party (or, if so authorized by the Disclosing Party, destroy) all
Confidential Information obtained from the Disclosing Party, together with any copies, extracts or reproductions thereof in any form
whatsoever; (ii) surrender to the Disclosing Party (or at the option of the Disclosing Party, destroy) any working papers or other
documents or tangible manifestation prepared by or for the use of the Receiving Party which are based upon or which contain,
describe or otherwise reveal, in whole or in part, any Confidential Information; and (iii) delete and erase (or cause to be deleted
and erased) from the computers, computer files, retrieval systems, databases, storage media and memory devices of the Receiving
Party all copies and versions of any of the foregoing.

 

5.2  
Exclusions. Section 5.1 shall not apply to the disclosure of Confidential Information if and to the extent: (a) such
disclosure is required by law or in order to enforce any rights pursuant to this Agreement in legal proceedings; or (b) such disclosure
is required by any competent regulatory authority including without limitation, any stock exchange; or (c) such information was obtained
from a Third Party lawfully possessed of such information and not in violation of any confidentiality restrictions or is in the public
domain other than through breach of this clause, provided that any Confidential Information shall only be disclosed after notification
to the other Party to the extent permitted by applicable law.

 

5.3  
Equitable Relief. The Parties acknowledge that the breach or non-performance by the Receiving Party of its responsibilities
and obligations specified in this Section 5 would cause the Disclosing Party immediate and irreparable harm for which monetary
damages alone would not be an adequate remedy. Accordingly, if any such non-performance or breach by the Receiving Party occurs, or is
threatened or anticipated to occur, the Parties agree that the Disclosing Party will be entitled to seek, in addition to any other remedies,
specific performance and/or injunctive relief, and the Receiving Party will not oppose any such application, or require the Disclosing
Party to post a bond or other security (even if otherwise normally required).

 

     9

     

    

 

		6.	Representations and Warranties.

 

6.1  
HPX Delaware Representations. HPX Delaware hereby represents and warrants to GEO27 that the following representations and
warranties are true and correct and acknowledges that GEO27 is relying on such representations and warranties in entering into this Agreement:

 

(a)   
HPX Delaware is duly constituted, validly existing and in good standing under the laws of its constituting jurisdiction and has
full power and authority under all applicable laws to own its property and to carry on its affairs as they are presently conducted;

 

(b)  
The execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized
by all appropriate corporate action of HPX Delaware;

 

(c)   
This Agreement constitutes a legal, valid and binding obligation of HPX Delaware, enforceable against HPX Delaware in accordance
with its terms (except as such enforcement may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization,
or similar laws related to or limiting creditors’ rights generally or general principles of equity). None of the execution and delivery
of, and the performance by HPX Delaware of any covenant or obligation under this Agreement, contravenes, results in or will contravene,
violate or result in (with or without the giving of notice or lapse of time, or both) any breach or default of, or acceleration of any
obligation of HPX Delaware under any applicable law or any agreement to which it is a party;

 

(d)   
To the best of HPX Delaware’s knowledge and belief, there are no liens, hypothecs, mortgages, charges, security interests
or other encumbrances on or affecting the Licensed Technology licensed hereunder;

 

(e)   
To the best of HPX Delaware’s knowledge and belief, there are no Claims by Third Parties relating to the Licensed Technology
licensed hereunder, nor any violations, infringements or misappropriations of any Third Party’s rights by the Licensed Technology
licensed hereunder;

 

(f)    
To the best of HPX Delaware’s knowledge and belief, there are no Claims, problems or challenges with respect to the patentability,
enforceability or validity, as applicable, of the Licensed Patents;

 

(g)   
To the best of HPX Delaware’s knowledge and belief, there are no liabilities whatsoever with respect to the Licensed Patents
of any kind other than the due and punctual payment of patent fees;

 

(h)   
To the best of HPX Delaware’s knowledge and belief, neither HPX Delaware nor the Licensed Technology licensed hereunder are
subject to any restriction imposed by any Governmental Authority or subject to any applicable law, other than applicable patent and intellectual
property law, which restricts or interferes with the transactions contemplated herein, and to the extent any approvals or consents are
required from any Governmental Authority will make reasonable efforts to so obtain;

 

(i)    
To the best of HPX Delaware’s knowledge and belief, there is no Claim, demand, suit, action, cause of action, dispute, proceeding,
litigation, investigation, grievance, arbitration, government proceeding or other proceeding, including appeals and applications for review,
whether or not insured, in progress against, by, relating to or affecting the Licensed Technology licensed hereunder, nor are any of the
same pending or threatened. There is not at present outstanding against HPX Delaware any order of any Governmental Authority that adversely
affects the Licensed Technology licensed hereunder in any way that relates to this Agreement;

 

     10

     

    

 

(j)     Schedule
I sets forth a list of Licensed Patents owned or licensed by HPX Delaware which are related to the development of the Licensed
Products. To the best of HPX Delaware’s knowledge and belief, no Intellectual Property Rights of any Third Party whatsoever
are in any way incorporated or included in, or related to, the Licensed Patent Rights or which may have any adverse effect on the
Licensed Patent Rights;

 

6.2  
GEO27 Representations. GEO27 represents and warrants to HPX Delaware that the following representations and warranties are
true and correct and acknowledges that HPX Delaware is relying on such representations and warranties in entering into this Agreement:

 

(a)    
GEO27 is duly constituted, validly existing and in good standing under the laws of its jurisdiction of constitution and has full
power and authority under applicable corporate law to own its property and to carry on its affairs as they are presently conducted;

 

(b)   
The execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized
by all appropriate corporate action of GEO27; and

 

(c)   
This Agreement constitutes a legal, valid and binding obligation of GEO27, enforceable against GEO27 in accordance with its terms
(except as such enforcement may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, or similar laws
related to or limiting creditors’ rights generally or general principles of equity). The execution, delivery and performance of
this Agreement by GEO27 does not conflict with any agreement, instrument or understanding to which GEO27 is a party or by which it is
bound.

 

		7.	Indemnification.

 

7.1  
HPX Delaware Indemnity. Subject to the provisions of Section 4.5 hereof, HPX Delaware shall, and hereby irrevocably
undertakes to, indemnify, defend and hold harmless GEO27, its Affiliates and Sublicensees and their respective directors, officers, employees,
and agents, and their respective successors, heirs and assigns, from and against any Losses suffered or incurred by any one or more of
them, as a result of, based upon, or arising in connection, directly or indirectly, with: (a) any Claim the Licensed Technology hereunder
infringes the Intellectual Property Rights of a Third Party; (b) any breach of, or falsity or inexactitude in, any representation or warranty
made or given by HPX Delaware in this Agreement; (c) any failure by HPX Delaware (or any of its Affiliates) to duly and punctually perform
any covenant or obligation contained in this Agreement or in any document delivered pursuant to it; or (d) the gross negligence of HPX
Delaware.

 

7.2  
GEO27 Indemnity. GEO27 shall indemnify, defend and hold harmless HPX Delaware, its Affiliates and their respective directors,
officers, employees, and agents, and their respective successors, heirs and assigns, from and against any Losses suffered or incurred
by any one or more of them, as a result of, based upon, or arising in connection, directly or indirectly, with: (a) any Claim that the
Licensed Technology, or a Licensed Product infringe the Intellectual Property Rights of a Third Party to the extent caused by GEO27’s
modifications thereof; (b) any breach of, or falsity or inexactitude in, any representation or warranty made or given by GEO27 in this
Agreement; (c) any failure by GEO27 (or any of its Affiliates) to duly and punctually perform any covenant or obligation contained in
this Agreement or in any document delivered pursuant to it; or (d) the gross negligence of GEO27.

 

7.3  
Notice of Claim / Reasonable Assistance. The right of each of the foregoing Parties to receive indemnification pursuant
to this Section 7 is subject to that Party providing prompt written notice of a claim of indemnification to the Party having an
obligation to indemnify pursuant to this Section 7 and providing reasonable assistance requested by such Party in connection with
such claim.

 

     11

     

    

 

		8.	Term and Termination.

 

8.1  
Term. Unless terminated pursuant to this Section 8, this Agreement and the License
(subject to the limitations herein with respect to the Licensed Patents) herein granted shall remain in full force and effect in perpetuity
(“Term”).

 

8.2  
Termination by GEO27. GEO27 may terminate this Agreement in its sole discretion at any time during the Term hereof on not
less than one hundred twenty (120) days prior written notice to HPX Delaware.

 

		8.3	Termination by Either Party.

 

(a)   
Termination for Breach. In the event either Party shall be in breach of any material obligation hereunder, the non-breaching
Party may give written notice to the breaching Party specifying the claimed particulars of such breach, and in the event such material
breach is not cured, or effective steps to cure such material breach have not been initiated or are not thereafter diligently pursued
within one hundred and twenty (120) days following the date of such written notification, and, if so initiated and pursued, is not cured
within one hundred and eighty (180) days of such written notification, in addition to any other damages or remedies available to the non-breaching
Party, the non-breaching Party shall have the right thereafter to terminate this Agreement by giving not less than thirty (30) days prior
written notice to the breaching Party to such effect. Any termination by any Party under this Section 8.3(a) shall be without prejudice
to any damages or remedies to which it may be entitled from the other Party.

 

(b)   
Termination for Insolvency. Either Party may terminate this Agreement without notice if the other Party becomes insolvent,
makes or has made an assignment for the benefit of creditors, is the subject of proceedings in voluntary or involuntary bankruptcy instituted
on behalf of or against such Party (except for involuntary bankruptcies which are dismissed within ninety

(90) days), or has a receiver or trustee
appointed for substantially all of its property.

 

8.4  
Effect of Termination. Upon termination of this Agreement by GEO27 pursuant to Section 8.2 or 8.3(b), and
upon termination of this Agreement by HPX Delaware pursuant to Section 8.3, all rights and obligations under this Agreement shall
terminate (except as provided in Section 8.5) and all license rights shall revert to HPX Delaware and GEO27 shall return to HPX
Delaware all of HPX Delaware’s Confidential Information, including but not limited to, any Licensed Products.

 

8.5  
Survival. Expiration or termination of this Agreement shall not relieve the Parties of any obligation accruing prior to
such expiration or termination. Without limiting the foregoing, the obligations pursuant to Sections 1,
2.9 (upon termination of this Agreement by GEO27 pursuant to 8.3(b)), 4, 5,
6, 7, 9, 10 and
11, shall survive termination of this Agreement.

 

		9.	LIMITED LIABILITY.

 

IN NO EVENT SHALL EITHER PARTY BE
LIABLE, ONE TO THE OTHER, FOR INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES OF ANY KIND ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT,
EXCEPT TO THE EXTENT SUCH DAMAGES: (A) ARE INCLUDED IN AN AWARD AGAINST A PARTY RESULTING FROM A THIRD PARTY CLAIM FOR WHICH SUCH PARTY
IS INDEMNIFIED HEREUNDER; (B) ARE RELATED TO, OR ARISE FROM, PERSONAL INJURY, DEATH OR DAMAGE TO TANGIBLE PROPERTY; OR (C) ARE RELATED
TO OR ARISE FROM WILLFUL OR INTENTIONAL MISCONDUCT.

 

     12

     

    

 

		10.	NO WARRANTIES

 

EXCEPT AS OTHERWISE EXPRESSLY SET
FORTH IN SECTIONS 6.1 OR 6.2, NEITHER PARTY MAKES ANY REPRESENTATION OR EXTENDS ANY WARRANTIES OF ANY KIND, EITHER EXPRESS
OR IMPLIED, TO THE OTHER PARTY, INCLUDING ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

 

		11.	General Provisions.

 

11.1         
Notices. Any notice or document shall be deemed to be given or delivered to or received by a Party (a) if delivered in person,
at the time of delivery, (b) if sent by one Party to another Party within the same jurisdiction, at 10:00 a.m. on the second Business
Day (which for purposes of this Section means a day during which commercial banks in Toronto and New York are generally open for business)
after it was put into the post, or if sent by post by one Party to another Party in a different jurisdiction, at 10:00 a.m. (local time
at the place of destination) on the fifth Business Day after it was put into the post, or (c) if sent by fax, at the expiration of two
hours after the time of dispatch, if dispatched before 3:00 p.m. (local time at the place of destination) on any Business Day, and in
any other case at 10:00 a.m. (local time at the place of destination) on the next Business Day following the date of dispatch, in each
case, to such Party at the first fax number or address listed for such Party below. All notices, requests, claims, demands and other communications
under this Agreement shall be delivered to the Parties in person or sent to the address set forth below by registered post, postage prepaid
and return receipt requested or by facsimile (with confirmation of receipt) as follows:

 

If to HPX Delaware:

 

		Attention:	Corporate
Secretary

		Facsimile No.:	+1-604-682-2060

		Address:	654 – 999 Canada Place 

Vancouver, BC V6C 3E1

 Canada

 

If to GEO27:

 

		Attention:	Corporate
Secretary

		Facsimile No.:	+1-604-682-2060

		Address:	654 – 999 Canada Place

 Vancouver, BC V6C 3E1 

Canada

 

11.2        
Non-Competition. HPX Delaware shall not compete directly or indirectly with GEO27 anywhere in the Territory, including,
without limitation (a) providing any services within the Field of Use to any Third Party, or (b) licensing or sublicensing any Intellectual
Property Rights for use within the Field of Use, which would enable any Third Party to compete with GEO27 anywhere in the Territory.

 

11.3        
Severability. In the event that any provision of this Agreement is determined by a court of competent jurisdiction to be
unenforceable or invalid under any applicable law, such provision will be interpreted in a manner, or replaced by a provision, that, to
the greatest extent possible, effectuates the objectives of such provision within the limits of applicable law or applicable court decisions.
The unenforceability or invalidity of any such provision will in no event affect the validity, force or effect of the remaining provisions
of this Agreement.

 

     13

     

    

 

11.4         
Governing Law. Any claims or disputes arising out of or related hereto or to the transactions contemplated hereby or to
the inducement of any Party to enter herein, whether for breach of contract, tortious conduct or otherwise and whether predicated on common
law, statute or otherwise, shall in all respects be governed by and construed in accordance with the laws of the State of New York, including
all matters of construction, validity and performance, in each case without reference to any conflict of law rules that might lead to
the application of the laws of any other jurisdiction.

 

11.5        
Venue. Any suit or action of any kind brought to enforce any provision of this Agreement shall be brought in any court of
competent jurisdiction in the County of New York, State of New York, United States. The Parties consent to personal jurisdiction of and
venue in the state and federal courts within that county and hereby irrevocably waive any objections to such jurisdiction, including but
not limited to the laying of venue or based on the grounds of forum non conveniens, which it may now or hereafter have to the bringing
of any such action or proceeding in such respective jurisdictions. Each of the Parties hereto hereby irrevocably consents to the service
of process of any of the aforementioned courts in any such action or proceeding by the means set out for the giving of notice pursuant
to Section 11.1 of this Agreement. Nothing herein shall affect the right of any Party hereto to serve process in any other manner
permitted by law.

 

11.6        
Entire Agreement. This Agreement, together with the Schedules and other attachments hereto, contains the entire understanding
between the Parties with respect to the subject matter hereof and supersedes all prior agreements, understandings and negotiations with
respect to the subject matter hereof.

 

11.7        
Amendment. This Agreement may be amended only by an instrument in writing signed by all of the Parties.

 

11.8        
No Waiver. No omission or delay on the part of any Party in exercising its rights under this Agreement or in requiring due
and proper fulfillment by the other Party as set forth in this Agreement shall be deemed to constitute a waiver and no waiver by the Party
of any breach or default by the other Party shall operate as a waiver of any succeeding breach or other default or breach by the other
Party.

 

11.9        
Interpretation and Construction. References to Sections are to the Sections herein. The headings in this Agreement are included
for convenience of reference only and shall not in any way limit or affect the meaning or interpretation of any of the terms hereof. This
Agreement shall not be construed as creating a partnership between the Parties or joint venture of any kind or any other form of legal
association that would impose liability upon one Party for the acts or failure to act of the other Party. Nothing contained herein will
be construed as creating any agency, employment, franchise, partnership or other form of joint enterprise between the Parties. Neither
Party shall have, or hold itself out as having, the right or authority to assume or create any obligation or responsibility, whether express
or implied, on behalf of or in the name of the other, except with the express written consent of the other. Wherever any words are used
herein in the masculine, feminine or neuter gender, they shall be construed as though they were used in another gender in all cases where
they would so apply, and whenever any words are used herein in the singular or plural form, they shall be construed as though they were
also used in the other form in all cases where they would so apply.

 

11.10       Force
Majeure. Neither Party shall be liable for any default or delay in the performance of its obligations under this Agreement to
the extent such default or delay is caused, directly or indirectly, by fire, flood, earthquake, elements of nature or Acts of God;
acts of war, terrorism, riots, civil disorders, rebellions or revolutions; strikes, lockouts or labor difficulties; or any other
similar cause beyond the reasonable control of such Party (a “Force Majeure Event”). These delays shall
not constitute a breach of this Agreement and the non-performing Party will be excused from any further performance or observance of
the obligations so affected by the Force Majeure Event for as long as the Force Majeure Event exists and such Party continues to use its best
efforts to recommence performance or observance thereof whenever and to whatever extent possible without delay. Any Party so delayed
in its performance will immediately notify the other Party by telephone (confirmed
in writing within two (2) Business Days of the inception of such delay).

 

11.11       
Execution. This Agreement may be executed in two (2) or more counterparts,
each of which shall be deemed an original copy of this Agreement, and all of which together will constitute
one and the same agreement.

 

     14

     

    

 

IN
WITNESS WHEREOF, the Parties hereto, each acting under due
and proper authority, have executed this Technology License Agreement
effective as of the day, month and year first above written.

 

	 	HIGH POWER EXPLORATION INC.
	 	 
	 	By:	/s/ Mask Gibson
	 	 	Name: 	MARK GIBSON
	 	 	Title: 	CHIEF EXECUTIVE OFFICER 

 

     15

     

    

 

	 	    GE027 S.AR.L
	 	 

 

     16

     

    

 

SCHEDULE
I

 

Licensed Patents:

 

National Phase applications entitled
 “Sparkgap device, particularly high-voltage spark-gap device,” resulting from PCT International Patent Application No. PCT/FR
2004/001192, dated May 14, 2004, filed in Australia, Canada, China, South Korea, India, Japan and the United States.

 

All other patents and patent applications
with respect to the Licensed Field, including, for the avoidance of doubt, with respect to the Zeus and Typhoon Transmitters, issued or
licensed to HPX Delaware, or applied for by, or on behalf of, HPX Delaware as of the date hereof. This Schedule I may be amended
from time to time by mutual agreement by notation of the Parties without the need for a formal amendment to this Agreement to further
specify such patents and patent applications.

 

Territory: European Union

 

Licensed Field (Fields of Use): Geological
Survey for mineral exploration.

 

     17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]